| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |